• HSPA1A–DNAJB1 Regulation of NELF Condensates in Heat Stress

  2026-05-22

  This study reveals that molecular chaperones HSPA1A and DNAJB1 maintain the dynamic, reversible condensation of NELF, a key transcriptional pausing factor, during heat shock. Their activity safeguards transcriptional recovery by preventing aberrant NELF aggregation and ensuring proper RNA Pol II pausing, with implications for understanding stress-adaptive gene regulation.

• WAY-100635: Potent 5-HT1A Antagonist for Neuroscience Resear

  2026-05-22

  WAY-100635 is a highly selective serotonin 5-HT1A receptor antagonist. It enables precise interrogation of serotonergic mechanisms in behavioral and imaging studies. Used extensively in neuroscience receptor pharmacology, its potency and selectivity are validated by both product and peer-reviewed evidence.

• NU7441 (KU-57788) in DNA Repair Research: Workflows & Tips

  2026-05-21

  NU7441 (KU-57788) delivers highly selective DNA-PK inhibition, empowering researchers to dissect DNA repair, cell cycle arrest, and cancer sensitization with precision. This guide details practical workflows, troubleshooting, and cross-domain insights for maximizing assay reproducibility in oncology and neuroinflammation studies.

• Bradford Protein Assay Kit: Accurate Protein Quantification

  2026-05-21

  The Bradford Protein Assay Kit (SKU: K4103) enables rapid, sensitive, and reproducible quantification of protein concentration in solution. It is best suited for standard protein quantification workflows in research applications such as enzyme assays, protein purification, and molecular biology. This kit is not intended for samples with high detergent content or those incompatible with Coomassie dye chemistry.

• RNA Pol II Inhibition Triggers Apoptosis via Pol IIA Loss, N

  2026-05-20

  Harper et al. (2025) reveal that cell death from RNA Pol II inhibition results from active apoptotic signaling initiated by the loss of hypophosphorylated RNA Pol IIA, rather than from passive mRNA decay. This finding challenges prevailing assumptions and informs the design of targeted DNA damage response research and cancer biology studies.

• Cy3 TSA Fluorescence System Kit: Unveiling Quantitative Sign

  2026-05-20

  Explore how the Cy3 TSA Fluorescence System Kit empowers quantitative, high-sensitivity detection of biomolecules in immunohistochemistry and beyond. This article uniquely bridges molecular amplification principles with practical assay optimization, providing actionable insights for research excellence.

• p-Cresyl Sulfate Drives Valvular Calcification via Klotho/SI

  2026-05-19

  The reference study demonstrates that p-cresyl sulfate, a key uremic toxin, directly promotes calcification in aortic valvular interstitial cells by perturbing klotho and SIRT1 signaling pathways. These findings clarify how p-tolyl hydrogen sulfate exacerbates cardiovascular risk in chronic kidney disease, highlighting intervention points for future vascular complication studies.

• Ibrexafungerp (MK 3118): Mechanism, Efficacy, and Clinical L

  2026-05-19

  Ibrexafungerp is a novel oral triterpenoid antifungal targeting 1,3-β-D-glucan synthase, demonstrating potent activity against fluconazole- and echinocandin-resistant Candida species. Its unique mechanism and efficacy in acidic environments support its use in vulvovaginal and invasive candidiasis, as confirmed by multiple in vitro and in vivo studies.

• XAV939 Inhibition of Wnt/β-catenin Does Not Ameliorate UC In

  2026-05-18

  This study rigorously evaluated the effect of XAV939-mediated inhibition of the Wnt/β-catenin pathway and SOX9 on inflammation in a dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) mouse model. Despite effectively suppressing Wnt/β-catenin signaling, XAV939 did not reduce intestinal inflammation, highlighting the complexity of UC pathogenesis and the need for refined mechanistic targeting.

• P2Y2 Receptor Activation Drives Microglial Aβ Clearance in A

  2026-05-18

  Kim et al. reveal that nucleotides released by amyloid β1–42-treated microglia activate P2Y2 receptors, boosting microglial migration and amyloid uptake—a process crucial for amyloid clearance in Alzheimer’s disease. This mechanistic insight positions P2Y2R as a potential therapeutic target and provides a foundation for experimental modulation of neuroimmune signaling.

• Dimethyloxalylglycine (DMOG): Technical Guidance for Hypoxia

  2026-05-17

  Dimethyloxalylglycine (DMOG) is a cell-permeable inhibitor of prolyl-4-hydroxylase domain enzymes, providing a controlled method to stabilize hypoxia-inducible factors in vitro and in vivo. It is recommended for research workflows focused on hypoxia signaling pathway modeling and inflammation studies, but is not suitable for diagnostic or clinical applications.

• Pseudo-UTP in mRNA Synthesis: Beyond Stability to Immune Eng

  2026-05-16

  Explore how pseudo-modified uridine triphosphate (Pseudo-UTP) advances mRNA synthesis with pseudouridine modification, not only enhancing RNA stability but also enabling precise immune modulation. This article delivers actionable protocol guidance and a unique analysis of UTR-based translational control, extending beyond prior reviews.

• Sunitinib: Multi-Targeted Receptor Tyrosine Kinase Inhibitor

  2026-05-15

  Sunitinib empowers cancer researchers to probe RTK-driven pathways, angiogenesis, and apoptosis with precision, especially in challenging models like ATRX-deficient gliomas and renal cell carcinoma. This guide demystifies advanced protocol enhancements, troubleshooting, and data-driven approaches for maximizing reproducibility and translational relevance.

• IL-21-Dependent Ly6C+Ly6G+CD4+ T Cells Enhance Antibacterial

  2026-05-15

  This study identifies a novel IL-21-dependent Ly6C+Ly6G+CD4+ T cell subset in the lungs that boosts macrophage-mediated antibacterial defense during Actinobacillus pleuropneumoniae infection in mice. By integrating high-dimensional mass cytometry and functional assays, the authors reveal how IL-21 signaling orchestrates immune cell differentiation and function, suggesting new therapeutic targets for bacterial pneumonia.

• Caspofungin: Applied Workflows for Antifungal Research Excel

  2026-05-14

  Caspofungin is a benchmark lipopeptide antifungal drug enabling researchers to dissect Candida cell wall biosynthesis and overcome azole resistance. This guide translates recent breakthroughs and experimental best practices into actionable protocols and troubleshooting strategies for high-reproducibility antifungal assays.

16455 records 1/1097 page Next 12345 下5页 Last page